BCL2 and acute myeloid leukemia: Studies demonstrating increased expression of BCL-2 in Leukemia stem cells and its ability to induce differential apoptosis compared to HSC with inhibition of BCL-2 in Acute Myeloid Leukemia [45] led to further studies that evaluated different BCL-2 inhibitors in AML.